Pre‑treatment evaluation and diagnostic documentation

An evaluation (in person or via telemedicine) by a qualified physician—or an Advanced Practice Provider working under the direct supervision of a physician—and a formal diagnosis by that provider are required before beginning any OSA treatment.

• Diagnosis must be performed by a qualified physician or an Advanced Practice Provider under direct physician supervision.
• The diagnosing provider must recommend the course of treatment prior to initiating therapy.

Prior authorization for implantable neurostimulation devices

Requests for implantable neurostimulation devices (and associated implantation/revision/removal/programming services) typically require prior authorization; include applicable device/procedure codes and documentation supporting device eligibility.

• Codes such as 64582–64584 and 93150–93153 are listed for implantation, revision, removal, and programming and are subject to prior authorization.
• Supply/implant HCPCS/L-codes (e.g., L8679, L8680, L8686) and device pulse‑generator codes should be included with requests when applicable.

Prior authorization expectations for oral appliance therapy

For oral appliance therapy (OAT), prior authorization/authorization requests should document that a qualified dentist constructed an adjustable, titratable custom appliance and that follow‑up sleep testing and periodic dental/sleep‑physician visits are planned, consistent with guideline recommendations.

• Custom, titratable appliances (HCPCS E0486/K1027) are preferred over prefabricated devices (E0485).
• Documentation should show dentist oversight and a plan for follow‑up sleep testing to confirm efficacy.

HNS: prior CPAP failure/intolerance required

Prior authorization for hypoglossal nerve stimulation requires documentation that PAP therapy resulted in no therapeutic efficacy, was refused, or was not tolerated, plus objective sleep metrics consistent with device trial populations (e.g., baseline AHI/ODI).

• Provider documentation must state PAP failure, intolerance, or refusal from the treating clinician.
• Objective baseline polysomnography metrics (AHI/ODI) consistent with trial/inclusion criteria should be provided.

Prior authorization expectations for implantable neurostimulation

Prior authorization for implantable neurostimulation (HNS or PNS) should include disease severity, prior therapies tried, and device‑specific eligibility testing; pembedded devices may require reference to trial evidence but also have known evidence limitations.

• Document AHI severity and prior guideline‑recommended therapies attempted.
• For HNS, include DISE findings (absence of complete concentric collapse) when applicable; for PNS (remedē) include prior therapy attempts and trial AHI thresholds.

Device‑specific prior authorization

When requesting coverage for an upper‑airway stimulation device, reference the FDA‑approved device/model and related PMA(s) (for example, Inspire PMA P130008 and supplements) and include the device model in the authorization request.

• Include the Inspire PMA identifier (P130008 and supplements) or equivalent device PMA when applicable.
• State device model (e.g., Inspire Model 3150 IPG) and confirm the patient meets device‑specific eligibility criteria described in the PMA.

Pre‑treatment evaluation and diagnosis requirement

An evaluation and diagnosis by a qualified physician or an Advanced Practice Provider under direct physician supervision is required prior to beginning treatment; the diagnosing provider must recommend the course of treatment.

• This requirement applies to both nonsurgical and surgical treatments per the revised policy language.
• Diagnosis must be documented in the medical record before initiating treatment.

Prior authorization and applicable codes

Certain newly added CPT codes (e.g., 64568, 64569) are included in the policy’s applicable codes and may require prior authorization; include these codes on requests and supply supporting documentation of medical necessity.

• Added CPT codes 64568 and 64569 were incorporated into the applicable codes list.
• Listing a code does not guarantee coverage; benefit coverage is subject to federal/state/contractual rules.

PAP trial requirement

PAP (Positive Airway Pressure) therapy must have been attempted and shown ineffective, not tolerated, or refused before considering oral appliance therapy or certain surgical/device interventions, unless an exception is documented.

• Documentation from the treating physician or Advanced Practice Provider that PAP resulted in no therapeutic efficacy or that the patient is intolerant/refused is required for OAT consideration.
• Exceptions are considered when surgery is indicated because of major anatomic abnormality per guidelines.

Treatment options list

Treatment options enumerated in the policy include lifestyle modification, positional therapy, PAP, oral appliances, electrostimulation devices, and surgery; use guideline‑recommended stepwise selection with CPAP generally first‑line.

• CPAP/automatic PAP is recommended as initial therapy for most adult patients (ACP, AASM guidance).
• Oral appliances, positional therapy, or other alternatives are options for select patients intolerant of CPAP.

Stepwise treatment preference

Clinical guidance and evidence summarized in the policy indicate CPAP is generally preferred first; alternative therapies (oral appliances, myofunctional therapy, positional therapy) are considered when CPAP fails or is not tolerated.

• Guidelines (AASM, ERS, ACP) recommend CPAP as initial therapy for moderate‑severe OSA.
• Oral appliance therapy is suggested for patients intolerant of CPAP and should be delivered and followed by qualified dentists and sleep physicians.

HNS as second‑line therapy

Hypoglossal nerve stimulation is evaluated and used as a second‑line therapy after documented PAP failure or intolerance in study populations (e.g., STAR trial); authorization should reflect prior PAP attempts and objective metrics.

• STAR and comparative analyses enrolled patients who had difficulty accepting or adhering to CPAP; prior PAP attempts must be documented.
• Provide baseline PSG metrics (AHI/ODI) consistent with trial inclusion.

Step therapy / prior therapies

Evidence reports for device and surgical therapies emphasize that study participants received guideline‑recommended therapy before enrollment; therefore, documentation of stepwise failure/intolerance of noninvasive therapies is expected before implantable or surgical therapies.

• Include documentation that guideline‑recommended therapies were attempted and reasons for failure/intolerance.
• Authorization requests lacking such documentation may be incomplete.

Stepwise treatment expectations

Policy requires a stepwise approach: CPAP (or oral appliance for select mild–moderate OSA) is first‑line; surgical options are considered when noninvasive therapies are unsuccessful or not tolerated and criteria are met.

• Surgical evaluation should document failure/intolerance of CPAP or that major anatomic abnormality makes surgery appropriate.
• Provide objective preoperative PSG within prior 6 months and other required assessments as indicated.

Oral appliance prior therapy expectation

Oral Appliance Therapy may be considered as an alternative to failed PAP therapy; provider documentation that PAP therapy resulted in no therapeutic efficacy or that the individual is intolerant or has refused PAP is required to support OAT.

• Documentation must come from the treating physician or Advanced Practice Provider.
• Oral appliances must meet the policy’s diagnosis requirements and be documented by a sleep study (attended PSG or HSAT).

Stepwise therapy expectations

For surgical and device therapies, the policy emphasizes meeting the policy’s diagnostic criteria (e.g., AHI/RDI thresholds) and documentation of prior therapy attempts or failure/intolerance (including attempts to improve adherence) where applicable.

• Surgical candidacy generally requires AHI ≥ 15 or RDI ≥ 15 as determined by attended polysomnography and documentation of PAP failure/intolerance.
• Adolescent HNS for Down syndrome requires meeting the policy’s diagnosis criteria and documented attempts to improve PAP adherence prior to labeling PAP as failed.

Medical record documentation required

The patient's medical record must contain legible documentation of relevant history, physical exam, and diagnostic test results that fully support medical necessity; absence of adequate records may result in denial.

• Records may be requested for review and must be made available upon request.
• Documentation should be maintained in the medical record and be legible.

Coding clarification: HCPCS code E0486 and dental codes

HCPCS E0486 applies to custom‑fabricated oral devices and includes fitting and adjustment; dental service codes (D9947, D9948, D9949) are generally excluded from medical plan coverage—verify federal/state/contractual rules.

• Use E0486/K1027 for custom fabricated, adjustable oral appliances (includes fitting/adjustment).
• Dental procedure codes are typically excluded from medical coverage—confirm contractual/federal/state rules before coverage decisions.

Documentation for OAT

When OAT is prescribed, documentation should show that a qualified dentist constructed an adjustable, titratable appliance and that follow‑up sleep testing and periodic dental and sleep‑physician visits are planned.

• Include documentation of the qualified dentist’s role in construction and follow‑up plans.
• Follow‑up sleep testing should be planned to confirm or improve treatment efficacy.

Suggested supporting documentation

Medical record documentation to support requests should include baseline AHI, documentation of prior CPAP intolerance or failure, BMI, and objective outcome measures (AHI/ODI) consistent with trial populations for HNS.

• Provide baseline PSG results (AHI) and ODI when available.
• Include BMI and objective outcome measures used in cited trials (e.g., STAR) to support medical necessity.

Required clinical documentation

Providers must document baseline attended polysomnography results (AHI), prior CPAP intolerance or failure, and, when relevant, drug‑induced sleep endoscopy findings (e.g., to exclude circumferential palatal collapse) prior to implantation or surgery.

• Preoperative PSG within the prior 6 months is expected when applicable.
• DISE findings should be provided when policy criteria (e.g., exclusion of complete concentric collapse) require it.

Required clinical documentation

Provide pre‑ and postoperative objective sleep study results (AHI, ESS, oxygen saturation) and documentation of CPAP intolerance or failure when requesting coverage for TORS or DOME procedures.

• Include objective measures of treatment effect (AHI, ESS, SaO2) pre‑ and post‑procedure.
• Document CPAP intolerance or failure and rationale for surgical approach.

Medical records and documentation

Medical records must fully support medical necessity; failure to provide requested documentation or inadequate records may lead to denial of requested services.

• Benefit coverage is determined by federal/state/contractual rules; documentation does not guarantee coverage.
• If documentation is incomplete or absent, authorization or payment may be denied.

PAP failure/intolerance documentation

Documentation from the treating physician or Advanced Practice Provider that PAP therapy resulted in no therapeutic efficacy or that the individual is intolerant or has refused PAP therapy is required where specified in the policy.

• This documentation is required to support oral appliance therapy and certain surgical/device interventions.
• Documentation must be explicit about therapeutic inefficacy or intolerance/refusal.

Lack of adequate medical record document

Lack of adequate medical record documentation supporting medical necessity may result in denial of requested services; provide complete, legible records on request.

• Failure to provide requested documentation or inadequate records may lead to denial.
• Ensure history, exam, and diagnostic tests supporting medical necessity are included.

Listing of a code in this policy does not imply coverage

Listing of a code in this policy does not imply the service is covered; benefit coverage is determined by federal/state/contractual requirements and other applicable policies.

• Inclusion of a code in the applicable codes list is for reference and does not guarantee reimbursement.
• Verify coverage against contractual, federal, and state rules.

Evidence‑based denial risk

Use of devices or therapies lacking quality supporting evidence (for example, nonsurgical electrical muscle stimulation/eXciteOSA, mandibular vertical repositioning devices, epigenetic appliances, ALF) may not be approved and can be denied as experimental or unproven.

• Devices without quality evidence may be considered experimental/unproven and lack coverage justification.
• Provide high‑quality supporting evidence when requesting coverage for such devices.

Evidence limitations may affect approval

Limited or low quality evidence for certain surgical/device approaches (e.g., TORS, DOME) and selection bias/nonstandardized reporting in studies may affect approval; requests lacking robust supporting data may be denied or require additional justification.

• TORS and DOME evidence is heterogeneous and largely retrospective, lacking well‑designed comparative trials and long‑term outcomes.
• Provide additional justification and robust documentation for coverage consideration.

Preoperative testing expectations

Preoperative testing expectations: absence of a documented preoperative attended polysomnography within the prior 6 months or absence of DISE (when required to exclude circumferential palatal collapse) may lead to ineligibility or denial for HNS or some surgical candidates.

• Obtain and document a preoperative PSG within 6 months when indicated.
• Provide DISE findings to demonstrate absence of complete concentric palatal collapse for HNS eligibility.

Insufficient evidence for DOME

DOME lacks randomized controlled trials and long‑term outcome data; absence of high‑quality evidence may trigger a medical necessity denial for DOME.

• Requests for DOME should include high‑quality comparative data and long‑term outcome justification when available.
• In the absence of such evidence, DOME may be considered investigational and denied.

Limited high‑quality evidence for TORS

TORS evidence is primarily retrospective and heterogeneous; lack of high‑quality comparative trials and variable complication rates may result in requests requiring additional justification or denial.

• Provide clear documentation of CPAP intolerance/failure and objective pre/postoperative PSG results.
• Be prepared to supply justification given heterogeneity and variable complication rates reported in systematic reviews.

Documentation‑related denial risk

Failure to provide medical record documentation that fully supports medical necessity (history, exam, diagnostic tests) or failure to provide requested records may result in denial; documentation does not guarantee coverage.

• Medical records must be legible and made available upon request.
• Benefit coverage is subject to federal/state/contractual rules in addition to medical necessity.

Medical record documentation

Lack of a complete medical record that supports medical necessity or failure to provide requested documentation may result in denial or inability to approve coverage.

• Ensure the medical record includes relevant medical history, physical exam, diagnostic test results, and treatment rationale.
• Timely response to requests for records is required to complete the review.